Cardiovascular Therapeutics.

نویسندگان

چکیده

برای دانلود رایگان متن کامل این مقاله و بیش از 32 میلیون مقاله دیگر ابتدا ثبت نام کنید

اگر عضو سایت هستید لطفا وارد حساب کاربری خود شوید

منابع مشابه

The Future of Cardiovascular Therapeutics.

The past several decades have seen spectacular successes in the development of new classes of highly effective drug therapies for common forms of cardiovascular disease. Arguably, the widespread use of these therapies, along with smoking cessation and nonpharmacological interventions, account for the decreasing incidence of death from cardiovascular disease. Nevertheless, cardiovascular disorde...

متن کامل

MicroRNA therapeutics for cardiovascular disease

MicroRNAs (miRNAs) are short, single-stranded, noncoding RNAs that exert their function through annealing with complementary sequences in specific messenger RNAs (mRNAs) to inhibit their translation into proteins. Even though it was only a decade ago that the first human miRNA was discovered, therapeutics to regulate miRNA function are already entering the clinical space. The main reasons for t...

متن کامل

MicroRNA therapeutics in cardiovascular medicine

Cardiovascular diseases are the most common causes of human morbidity and mortality despite significant therapeutic improvements by surgical, interventional and pharmacological approaches in the last decade. MicroRNAs (miRNAs) are important and powerful mediators in a wide range of diseases and thus emerged as interesting new drug targets. An array of animal and even human miRNA-based therapeut...

متن کامل

RNA Therapeutics for Treatment of Cardiovascular Diseases

Recent studies suggest that the majority of the human genome is transcribed, but only ≈2% account for protein coding exons. The remaining noncoding sequences include small noncoding RNAs, particularly microRNAs, which are ≈22 nucleotides in length. MicroRNAs posttranscriptionally control gene expression by targeting multiple mRNAs. By binding to the 3′UTR (untranslated region) of mRNAs, microRN...

متن کامل

Editorial Diabetic Endothelium Dysfunction, Cardiovascular Complications, and Therapeutics

1Vascular Biology Program, Boston Children’s Hospital, Harvard Medical School, Boston, MA 02115, USA 2Department of Internal Medicine, Charles R. Drew University of Medicine and Science and the University of California, Los Angeles, CA 90059, USA 3Department of Pharmacology, Yeungnam University, Daegu 712-749, Republic of Korea 4The Key Laboratory of Cardiovascular Remodeling and Function Resea...

متن کامل

ذخیره در منابع من


  با ذخیره ی این منبع در منابع من، دسترسی به آن را برای استفاده های بعدی آسان تر کنید

ژورنال

عنوان ژورنال: Postgraduate Medical Journal

سال: 2000

ISSN: 0032-5473

DOI: 10.1136/pmj.76.896.381d